A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

NCT00367445 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Inhaled Human Insulin (Exubera)
DRUG: Insulin Glargine (Lantus)

Sponsor

Pfizer